1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Neoplasms, Second Primary: new trials by email Literature Review of Neoplasms, Second Primary trials Research Report on Neoplasms, Second Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PREventing Second Cancers With DOSTARlimab Dostarlimab - Recurrent Cancer, Primary Cancer | Phase 2 | Recruiting | Centre Leon Berard | 400 | 2023-07-26 | 2024-07-15 |
Neoplasms (1) · Recurrence (1)
Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
dostarlimab (1)
France (1)